Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Biota is a world-leading antiviral drug discovery company with its headquarters in Melbourne, Australia. Biota’s first breakthrough was the discovery of zanamivir, the first neuraminidase inhibitor, subsequently marketed by GlaxoSmithKline as Relenza for the treatment of influenza. In partnership with Thermo Electron, Biota markets the FLU OIA® diagnostics range for the rapid detection of influenza. In partnership with Sankyo, Biota is engaged in the development of second generation flu antivirals (LANI or Long Acting Neuraminidase Inhibitors). Biota also has active discovery and development programs aimed at new therapies for diseases caused by Human Rhinovirus (common cold), RSV (Respiratory Syncytial Virus), HIV, and hepatitis C. ( www.biota.com.au )
Biota Holdings Limited
Unit 10 585 Blackburn Road
Notting Hill, Victoria 3168
AUSTRALIA
Tel: +61 3 9915 3700
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
About Progen: Progen Industries Limited is an Australian based globally focused biotechnology company committed to the discovery, development and commercialisation of small molecule pharmaceuticals for the treatment of cancer and other serious diseases. ( www.progen.com.au )
Progen Industries Limited
16 Benson St
Toowong, Queensland 4066
Australia
Tel: +61 7 3842 3333
Fax: +61 7 3720 9624
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Actelion Ltd is a biopharmaceutical company with its corporate headquarters in Allschwil/Basel, Switzerland. Actelion’s first drug Tracleer®, an orally available dual endothelin receptor antagonist, has been approved as a therapy for pulmonary arterial hypertension. Actelion markets Tracleer® through its own subsidiaries in key markets worldwide, including the United States (based in South San Francisco), the European Union, Japan, Canada, Australia and Switzerland. At the end of September 2006, Tracleer® was commercially available in 35 countries worldwide. Actelion, founded in late 1997, is a leading player in innovative science related to the endothelium – the single layer of cells separating every blood vessel from the blood ( www.actelion.com )
Actelion Ltd
PO Box 372
Frenchs Forest, New South Wales 1640
Australia
Tel: +61 2 9486 4600
Fax: +61 2 9986 1344
Industry: Pharmaceuticals, Biotechnology
Replikun Biotech Pty Limited is a private, venture capital backed company established in 2005. Replikun Biotech’s origins date back to 1960, when Professor Edwin Westaway isolated the Kunjin virus from Cx. annulirostris mosquitoes in northern Queensland. The virus was given the name of a nearby Aboriginal clan living on the Mitchell River. The discovery of Kunjin was exciting because it provided a safe means of studying flavivirus replication in the laboratory. In 1995, Professor Westaway and Associate Professor Alex Khromykh showed that the structural protein genes could be removed from the Kunjin genome without disturbing ( www.replikun.com )
Replikun Biotech Pty Limited
Level 1 80 Jephson Street
Toowong, Queensland 4066
AUSTRALIA
Tel: +61 7 3327 9829
Fax: +61 7 3720 9574
Industry: Pharmaceuticals, Biotechnology
Spinifex focuses on pain because it is an area of high unmet medical need, and therefore provides many commercial opportunities. Demand for pain drugs continues to increase, fuelling the growth of a market that is expected to be worth US,75 billion annually by 2010. With most types of pain still poorly treated, considerable investment is being made internationally in discovering novel approaches to treat pain, providing Spinifex with a wide choice of early-stage drugs from which to license products for development. ( www.spinifexpharma.com.au )
Spinifex Pharmaceuticals Pty Limited
Level 2, 147 Coronation Drive
Milton, Queensland 4064
AUSTRALIA
Tel: +61 7 3025 3216
Fax: +61 7 3025 3300
Industry: Pharmaceuticals, Biotechnology
MitoSciences was founded in the summer of 2003 by Drs Roderick Capaldi and Michael Marusich with the mission of advancing mitochondrial research, and in particular, efforts to understand the role of the organelle in human diseases. The Company has produced and continues to add to the world’s largest collection of anti-mitochondrial monoclonal antibodies. These antibodies are being sold for life sciences research, developed into kits for drug discovery and drug toxicity studies, as well as being developed into tools for the diagnosis of the many mitochondrial-related diseases and for diagnosing mitochondrial toxicity from HAART. The Company is located in the Riverfront Research Park of the University of Oregon. ( www.mitosciences.com )
MitoSciences Inc
Suite 1 134 Redfern Street
Redfern, New South Wales 2016
Australia
Tel: +61 2 9698 2022
Fax: +61 2 9698 1022
Industry: Pharmaceuticals, Biotechnology
ACYTE Biotech was incorporated in June 2000 to commercialise intellectual property arising from a mammalian cell research group at the University of New South Wales. The two co-founders of the company are Professor Peter Gray and A/Professor Noelle-Anne Sunstrom. Major R&D activities for the company commenced in 2002. Since then, ACYTE’s operations have been funded by contracts with major international pharma and biotech companies and three Biotechnology Innovation Fund grants (BIF grants) from the Australian Federal Government. ACYTE staff has expertise ranging from molecular biology through to cell culture and protein ( www.acyte.com )
Acyte Biotech Pty Ltd
Rupert Myers Building Barker Street
Sydney, New South Wales 2052
Australia
Tel: +61 2 9385 3693
Industry: Pharmaceuticals, Biotechnology
Marinova is an Australian biotechnology company dedicated to the development of biological actives from marine macroalgae. The company is based in Hobart, Tasmania, and provides products ranging from seaweed blends to characterised component fractions. Marinova’s research and development program focuses on fucoidans, sulphated polysaccharides found in brown macroalgae and echinoderms. The company has isolated fucoidans from over 10 different species, and is a world leading resource for companies looking to utilise fucoidans as pharmaceutical, nutraceutical or cosmetic ingredients. ( www.marinova.com.au )
Marinova Pty Ltd
Level 7 39 Murray St
Hobart, Tasmania 7000
Australia
Tel: +61 3 6231 9988
Fax: +61 3 6231 9987
Industry: Pharmaceuticals, Biotechnology
MINOMIC PTY LTD – Blazing a growth path via research excellence and strategic partnerships Minomic is a leader in the field of proteomics, with its world-class laboratory developing non-invasive diagnostic technologies for type-2 diabetes and providing contract research services. ( www.minomic.com )
Minomic Pty Ltd
Level 3, 126 Greville St Chatswood West, NSW 2067 PO Box 664
Harbord, New South Wales 2096
Australia
Tel: +612 9422 3055
Fax: +612 9422 3093
Industry: Pharmaceuticals, Biotechnology
Imugene is developing and commercialising a range of biological animal health products for the production animal markets worldwide. The Imugene ‘Vector’ products improve the health and welfare of animals and reduce or eliminate the use of chemicals and drugs, particularly antibiotics, in production animals. ( www.imugene.com )
Imugene Limited
Level 1 14 20 Delhi Road
North Ryde, New South Wales 2113
Australia
Tel: +61 2 9870 7330
Fax: +61 2 9888 9338